Riskpilot← Back to searchSign inGet full accessMediplast AB
ABActiveOrg 5561409011Bronsåldersgatan 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 1970100-199 employees
Revenue 2024
SEK 788,2M
+1% vs 2023
EBITDA margin
9.3%
+59% vs 2023
Equity ratio
20.4%
Financial strength
Net profit 2024
SEK 212K
-64% vs 2023
| Revenue | SEK 788,2M | +1% |
| EBITDA | SEK 73,2M | +59% |
| Net profit | SEK 212K | -64% |
| Total assets | SEK 290,9M | +14% |
| Equity | SEK 59,3M | +0% |
| Employees | — | — |
Legal name
Mediplast AB
Org number
5561409011
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 november 1970
Share capital
SEK 13 479 000
Employees
100-199
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska importera, exportera, bedriva partihandel med samt tillverka medicinsk-teknisk utrustning ävensom idka annnan därmed förenlig verksamhet.
Address
Bronsåldersgatan 2
Phone
+46406712300
Email
info@mediplast.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 455 727 | 528 417 | 644 117 | 909 857 | 683 601 | 685 667 | 780 845 | 788 166 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | 30 740 | 27 744 | 45 023 | 42 034 | 103 193 | 59 508 | 41 529 | 46 033 | 73 178 |
| Depreciation & amort. | −2 386 | −3 320 | −4 197 | −6 295 | −9 529 | −9 033 | −8 233 | −8 277 | −6 838 |
| EBIT | 28 354 | 24 424 | 40 826 | 35 739 | 93 664 | 50 475 | 33 296 | 37 756 | 66 340 |
| Net financials | 28 741 | 1 889 | 164 | −1 056 | −1 438 | 1 500 | −44 | −3 461 | −525 |
| Profit before tax | 28 395 | 613 | 240 | 533 | 2 226 | 975 | 752 | 1 133 | 1 204 |
| Tax | −76 | −19 | −209 | −480 | −611 | −476 | −478 | −545 | −992 |
| Net profit | 28 319 | 594 | 31 | 53 | 1 615 | 499 | 274 | 588 | 212 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 362 372 | 211 570 | 199 320 | 241 165 | 242 722 | 232 629 | 234 398 | 254 673 | 290 851 |
| Equity | 110 472 | 96 070 | 56 095 | 56 148 | 57 763 | 58 262 | 58 536 | 59 124 | 59 336 |
| Long-term debt | 105 782 | 0 | 5 000 | 5 000 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 146 118 | 115 500 | 138 225 | 180 017 | 184 959 | 174 310 | 175 862 | 195 549 | 231 515 |
| Total debt | 251 900 | 115 500 | 143 225 | 185 017 | 184 959 | 174 310 | 175 862 | 195 549 | 231 515 |
EBITDA margin
9.3%
This company
15.8%
Market median
-41% vs market
20162024
Equity ratio
20.4%
This company
38.2%
Market median
-47% vs market
20162024
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20162024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20162024
Asset turnover
2.71×
This company
1.12×
Market median
+142% vs market
20162024
Debt / equity
3.90×
This company
0.62×
Market median
-529% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-04-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MC Chief Auditor | Chief Auditor | 2021 | — | — |
JO Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
KS Chief Auditor | Chief Auditor | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
AddLife Development AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AddLife AB
Mediplast AB Board members of Mediplast AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mona Christina Nilsson | Chief Auditor | 0 companies |
| Johan Olof Mårten Bongstorp | Chief Executive Officer | 0 companies |
| Karl Sven Henrik Järdler | Chief Auditor | 0 companies |
| Eva Kristina Willgård | Board of Directors | 0 companies |
| Anna Christina Rubenhag | Board of Directors | 0 companies |
| Rolf Ove Stefan Sandin | Chairman | 0 companies |
| Nathan Pettitt | Board of Directors | 0 companies |
| Per Anders Wahlstedt | Board of Directors | 0 companies |
| Peter Mikael Simonsbacka | Board of Directors | 0 companies |
| Tara Noelle Kearney | Chairman | 0 companies |
| Fredrik Olof Dalborg | Chairman | 0 companies |
| Martin Almgren | Chairman | 0 companies |